Impact of Graft Cell Dose on Transplant Outcomes following Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation: Higher CD34+ Cell Doses Are Associated with Decreased Relapse Rates-Reference-Cited by-同舟云学术

Impact of Graft Cell Dose on Transplant Outcomes following Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation: Higher CD34+ Cell Doses Are Associated with Decreased Relapse Rates

Published:2008-04 Issue:4 Volume:14 Page:449-457
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Nakamura Ryotaro,Auayporn Nademanee,Smith David D.,Palmer Joycelynne,Sun Joel Y.,Schriber Jeffrey,Pullarkat Vinod,Parker Pablo,Rodriguez Roberto,Stein Anthony,Rosenthal Joseph,Wang Shirong,Karanas Chatchada,Gaal Karl,Senitzer David,Forman Stephen J.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies;Mavroudis;Blood,1996

2. Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back;Nakamura;Br J Haematol,2001

3. Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses;Ringden;Br J Haematol,2003

4. Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation;Dominietto;Blood,2002

5. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose;Sierra;Blood,1997

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD34+ cell yield among healthy donors: Large‐scale model development and validation;Journal of Clinical Apheresis;2024-06

2. The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation;Frontiers in Immunology;2024-05-16

3. High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality;Transfusion;2024-05

4. Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide – A retrospective single-center study with a Japanese cohort;Blood Cells, Molecules, and Diseases;2024-03

5. Hematopoietic Cell Collection;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024